Literature DB >> 10444361

Infusion of bispecific monoclonal antibody complexes into monkeys provides immunologic protection against later challenge with a model pathogen.

M L Craig1, M L Reinagel, E N Martin, R Schlimgen, A Nardin, R P Taylor.   

Abstract

Heteropolymers (HP), bispecific mAbs which bind target pathogens to primate erythrocytes via complement receptor 1, facilitate clearance of pathogens from the bloodstream by targeting them for destruction in the liver without causing lysis or clearance of the erythrocytes. We show that when HP prepared with mouse IgG are intravenously infused into monkeys one or more times prior to exposure to a prototype pathogen, they bind to erythrocytes and remain in the circulation long enough to act as "sentinels," preventing pathogen invasion of the bloodstream. The effectiveness of HP as sentinels is limited both by the monkey's immune response to the HP and, prior to the immune response, by a gradual loss of the HP from monkey erythrocytes over a period of 1 week, and we have investigated possible causes of this HP loss. In overview, our results suggest that HP prepared with mouse IgG are able to effectively function as sentinels for a minimum of 4 days and, after repeat infusion, possibly for up to 2 weeks. Copyright 1999 Academic Press.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10444361     DOI: 10.1006/clim.1999.4739

Source DB:  PubMed          Journal:  Clin Immunol        ISSN: 1521-6616            Impact factor:   3.969


  7 in total

Review 1.  Drug delivery by red blood cells: vascular carriers designed by mother nature.

Authors:  Vladimir R Muzykantov
Journal:  Expert Opin Drug Deliv       Date:  2010-04       Impact factor: 6.648

2.  A transgenic mouse model for studying the clearance of blood-borne pathogens via human complement receptor 1 (CR1).

Authors:  A Repik; S E Pincus; I Ghiran; A Nicholson-Weller; D R Asher; A M Cerny; L S Casey; S M Jones; S N Jones; N Mohamed; L B Klickstein; G Spitalny; R W Finberg
Journal:  Clin Exp Immunol       Date:  2005-05       Impact factor: 4.330

3.  Expression of a functional single-chain variable-fragment antibody against complement receptor 1 in Streptococcus gordonii.

Authors:  Jennifer B Knight; Scott A Halperin; Kenneth A West; Song F Lee
Journal:  Clin Vaccine Immunol       Date:  2008-04-02

Review 4.  Delivery of drugs bound to erythrocytes: new avenues for an old intravascular carrier.

Authors:  Carlos H Villa; Daniel C Pan; Sergei Zaitsev; Douglas B Cines; Donald L Siegel; Vladimir R Muzykantov
Journal:  Ther Deliv       Date:  2015-07

5.  Antibody to the type 3 capsule facilitates immune adherence of pneumococci to erythrocytes and augments their transfer to macrophages.

Authors:  Jie Li; Alexander J Szalai; Susan K Hollingshead; Moon H Nahm; David E Briles
Journal:  Infect Immun       Date:  2008-11-10       Impact factor: 3.441

6.  Clearance of amyloid-beta with bispecific antibody constructs bound to erythrocytes.

Authors:  Ronald P Taylor; Margaret A Lindorfer; John P Atkinson
Journal:  Alzheimers Dement (N Y)       Date:  2020-08-27

Review 7.  Therapeutic applications of monoclonal antibodies.

Authors:  Mitchell Berger; Vidya Shankar; Abbas Vafai
Journal:  Am J Med Sci       Date:  2002-07       Impact factor: 2.378

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.